Our business is helping companies succeed in mending broken hearts. Regenerative Cardiology is all that we do for our clients, and do it as no one else does.

We solved the mystery behind the translational paradox that for over a decade frustrated countless efforts to translate the positive animal results to successful human cardiac repair trials. Now we not only know the cause for those failed trials, we invented a solution to the problem.

Backed by three patent applications, on a subject matter that neither existed in text books nor in research journals, prior to launch of our venture, we are enabling non-invasive ways of heart repair.